Company Name: Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company. The company uses its proprietary RNA interference (RNAi) technology platform to develop treatments for genetically defined cancers and rare inherited liver diseases.
Ticker Symbol: DRNA (NASDAQ)
Company Website: http://dicerna.com
Social Media: Dicerna Pharmaceuticals LinkedIn
Headquarters: Cambridge, Massachusetts
